Complete reference list (PDF 1191 KB) - Department of Health and ...
Complete reference list (PDF 1191 KB) - Department of Health and ...
Complete reference list (PDF 1191 KB) - Department of Health and ...
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
113. Wilfert CM, Gross PA, Kaplan JE, et al. Quality st<strong>and</strong>ard for the enumeration <strong>of</strong> CD4 +<br />
lymphocytes in infants <strong>and</strong> children exposed to or infected with human immunodeficiency virus.<br />
Clinical Infectious Diseases 1995;21 Suppl 1:S134-5.<br />
114. Steele AD, Cunliffe N, Tumbo J, et al. A review <strong>of</strong> rotavirus infection in <strong>and</strong> vaccination <strong>of</strong><br />
human immunodeficiency virus-infected children. Journal <strong>of</strong> Infectious Diseases 2009;200 Suppl<br />
1:S57-62.<br />
115. Steele AD, Madhi SA, Louw CE, et al. Safety, reactogenicity, <strong>and</strong> immunogenicity <strong>of</strong> human<br />
rotavirus vaccine RIX4414 in human immunodeficiency virus-positive infants in South Africa.<br />
Pediatric Infectious Disease Journal 2011;30:125-30.<br />
116. Scott P, Moss WJ, Gilani Z, Low N. Measles vaccination in HIV-infected children: systematic<br />
review <strong>and</strong> meta-analysis <strong>of</strong> safety <strong>and</strong> immunogenicity. Journal <strong>of</strong> Infectious Diseases 2011;204<br />
Suppl 1:S164-78.<br />
117. World <strong>Health</strong> Organization (WHO). Global Advisory Committee on Vaccine Safety, report <strong>of</strong><br />
meeting held 17–18 June 2009. Weekly Epidemiological Record 2009;84:325-32.<br />
118. Menson EN, Mellado MJ, Bamford A, et al. Guidance on vaccination <strong>of</strong> HIV-infected children in<br />
Europe. HIV Medicine 2012;13:333-6.<br />
119. Melvin AJ, Mohan KM. Response to immunization with measles, tetanus, <strong>and</strong> Haemophilus<br />
influenzae type b vaccines in children who have human immunodeficiency virus type 1 infection<br />
<strong>and</strong> are treated with highly active antiretroviral therapy. Pediatrics 2003;111:e641-4.<br />
120. Aurpibul L, Puthanakit T, Sirisanthana T, Sirisanthana V. Response to measles, mumps, <strong>and</strong><br />
rubella revaccination in HIV-infected children with immune recovery after highly active<br />
antiretroviral therapy. Clinical Infectious Diseases 2007;45:637-42.<br />
121. Stermole BM, Gr<strong>and</strong>its GA, Roediger MP, et al. Long-term safety <strong>and</strong> serologic response to<br />
measles, mumps, <strong>and</strong> rubella vaccination in HIV-1 infected adults. Vaccine 2011;29:2874-80.<br />
122. American Academy <strong>of</strong> Pediatrics, Committee on Infectious Diseases, Committee on Pediatric<br />
AIDS. Measles immunization in HIV-infected children. Pediatrics 1999;103:1057-60.<br />
123. Levin MJ, Gershon AA, Weinberg A, et al. Administration <strong>of</strong> live varicella vaccine to HIVinfected<br />
children with current or past significant depression <strong>of</strong> CD4 + T cells. Journal <strong>of</strong> Infectious<br />
Diseases 2006;194:247-55.<br />
124. Son M, Shapiro ED, LaRussa P, et al. Effectiveness <strong>of</strong> varicella vaccine in children infected with<br />
HIV. Journal <strong>of</strong> Infectious Diseases 2010;201:1806-10.<br />
125. Weinberg A, Levin MJ, MacGregor RR. Safety <strong>and</strong> immunogenicity <strong>of</strong> a live attenuated varicella<br />
vaccine in VZV-seropositive HIV-infected adults. Human Vaccines 2010;6:318-21.<br />
126. Centers for Disease Control <strong>and</strong> Prevention (CDC), Kaplan JE, Benson C, et al. Guidelines for<br />
prevention <strong>and</strong> treatment <strong>of</strong> opportunistic infections in HIV-infected adults <strong>and</strong> adolescents:<br />
recommendations from CDC, the National Institutes <strong>of</strong> <strong>Health</strong>, <strong>and</strong> the HIV Medicine Association<br />
<strong>of</strong> the Infectious Diseases Society <strong>of</strong> America. MMWR Recommendations <strong>and</strong> Reports<br />
2009;58(RR-4):1-207.<br />
127. Centers for Disease Control <strong>and</strong> Prevention (CDC), M<strong>of</strong>enson LM, Brady MT, et al. Guidelines<br />
for the prevention <strong>and</strong> treatment <strong>of</strong> opportunistic infections among HIV-exposed <strong>and</strong> HIV-infected<br />
children: recommendations from CDC, the National Institutes <strong>of</strong> <strong>Health</strong>, the HIV Medicine<br />
Association <strong>of</strong> the Infectious Diseases Society <strong>of</strong> America, the Pediatric Infectious Diseases<br />
Society, <strong>and</strong> the American Academy <strong>of</strong> Pediatrics. MMWR Recommendations <strong>and</strong> Reports<br />
2009;58(RR-11):1-166.<br />
128. Veit O, Niedrig M, Chapuis-Taillard C, et al. Immunogenicity <strong>and</strong> safety <strong>of</strong> yellow fever<br />
vaccination for 102 HIV-infected patients. Clinical Infectious Diseases 2009;48:659-66.<br />
129. Hesseling AC, Cotton MF, Fordham von Reyn C, et al. Consensus statement on the revised World<br />
<strong>Health</strong> Organization recommendations for BCG vaccination in HIV-infected infants. International<br />
Journal <strong>of</strong> Tuberculosis <strong>and</strong> Lung Disease 2008;12:1376-9.<br />
130. Mansoor N, Scriba TJ, de Kock M, et al. HIV-1 infection in infants severely impairs the immune<br />
response induced by Bacille Calmette-Guérin vaccine. Journal <strong>of</strong> Infectious Diseases<br />
2009;199:982-90.<br />
131. Tovo PA, de Martino M, Gabiano C, Galli L. Pertussis immunization in HIV-1-infected infants: a<br />
model to assess the effects <strong>of</strong> repeated T cell-dependent antigen administrations on HIV-1<br />
progression. Italian Register for HIV infection in children. Vaccine 2000;18:1203-9.
Change language